Daewoong Pharm ties with Sankyo Co. on hypertension drug

Published: 2004-11-04 06:58:00
Updated: 2004-11-04 06:58:00
Daewoong Pharm said it would join hands with Sankyo Co Ltd., Japan's second-largest drug maker to promote Sankyo's new one-daily hypertension treatment Olmesartan medoxomil in Korea.

Olmetec, a prodrug, is hydrolyzed to olmesartan during absorption from the gastrointestinal tract. Olmesartan i...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.